Curis to Present at Upcoming Healthcare Conferences in September
(NASDAQ:CRIS) LEXINGTON, Mass., Sept. 2, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small mol...
13 days ago